Abnormal expression of Period 1 (PER1) in endometrial carcinoma

Journal of Pathology

Volumn 206, Issue 1, 2005, Pages 111-120

  Yeh, Kun Tu ^a,b   Yang, Ming Yu ^c   Liu, Ta Chih ^c   Chen, Jui Chang ^a   Chan, Wen Ling ^a   Lin, Sheng Fung ^c   Chang, Jan Gowth ^a,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d Taipei Institute of Pathology   (Taiwan)

Author keywords

Cell cycle; Circadian cycle; Endometrial carcinoma; Expression; PER1; RT PCR

Indexed keywords

CYCLIN A; CYCLIN B; CYCLIN D1; MYC PROTEIN; PER1 PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CIRCADIAN RHYTHM; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; ENDOMETRIUM CARCINOMA; FEMALE; GENE; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PER1 GENE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CARCINOMA; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CIRCADIAN RHYTHM; CYCLIN A; CYCLIN B; CYCLIN D1; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 18144406584     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1756     Document Type: Article

References (35)

1. Dos Santos SI, Swerdlow AJ. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. Br J Cancer 1995; 72: 485-492.
2. Hoffman K, Nekhlyudar L, Deligdisch L. Endometrial carcinoma in elderly women. Gynecol Oncol 1995; 58: 198-201.
3. Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2001; 5: 341-354.
4. Inoue M. Current molecular aspects of the carcinogenesis of the uterine endometrium. Int J Gynecol Cancer 2001; 11: 339-348.
5. Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, et al. Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol 2001; 32: 569-577.
6. Salvesen HB, Akslenm LA. Molecular pathogenesis and prognostic factors in endometrial carcinoma. APMIS 2002; 110: 673-689.
7. Lalloo F, Evans G. Molecular genetics and endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2001; 15: 355-363.
8. Milde-Langosch K, Riethdorf S. Role of cell-cycle regulatory proteins in gynecological cancer. J Cell Physiol 2003; 196: 224-244.
9. Young MW, Kay SA. Time zones: a comparative genetics of circadian clocks. Nature Rev Genet 2001; 2: 702-715.
10. Strayer CA, Kay SA. The ins and outs of circadian regulated gene expression. Curr Opin Plant Biol 1999; 2: 114-120.
11. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002; 418: 935-941.
12. Roenneberg T, Merrow M. Circadian clocks - from genes to complex behavior. Reprod Nutr Dev 1999; 39: 277-294.
13. Allada R, Emery P, Takahashi JS, Rosbash M. Stopping time: the genetics of fly and mouse circadian clocks. Annu Rev Neurosci 2001; 24: 1091-1119.
14. Wager-Smith K, Kay SA. Circadian rhythm genetics: from flies to mice to humans. Nature Genet 2000; 26: 23-27.
15. Morse D, Sassone-Corsi P. Time after time: inputs to and outputs from the mammalian circadian oscillators. Trends Neurosci 2002; 25: 632-637.
16. Yamaguchi S, Isejima H, Matsuo T, Okura R, Yagita K, Kobayashi M, et al. Synchronization of cellular clocks in the suprachiasmatic nucleus. Science 2003; 302: 1408-1412.
17. Balsalobre A. Clock genes in mammalian peripheral tissues. Cell Tissue Res 2002; 309: 193-199.
18. Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D, Albrecht U, et al. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002; 110: 251-260.
19. Urs A. Functional Genomics of Sleep and Circadian Rhythm Invited Review: Regulation of mammalian circadian clock genes. J Appl Physiol 2002; 92: 1348-1355.
20. Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nature Rev Neurosci 2003; 4: 649-661.
21. Cermakian N, Boivin DB. A molecular perspective of human circadian rhythm disorders. Brain Res Brain Res Rev 2003; 42: 204-220.
22. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nature Rev Cancer 2003; 3: 350-361.
23. Chan TF, Su TH, Yeh KT, Chang JY, Lin TH, Chen JC, et al. Mutational, epigenetic and expressional analyses of caveolin-1 gene in cervical cancers. Int J Oncol 2003; 23: 599-604.
24. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2003; 21: 5427-5440.
25. Hrushesky WJ, Bjarnason GA. Circadian cancer therapy. J Clin Oncol 1993; 11: 1403-1417.
26. Lèvi F. Circadian chronotherapy for human cancers. Lancet Oncol 2001; 2: 307-315.
27. Leung WK, Yu J, Ng EKW, To KF, Ma PK, Lee TL, et al. Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer 2001; 91: 2294-2301.
28. Oster H, Werner C, Magnone MC, Mayser H, Feil R, Seeliger MW, et al. cGMP-dependent protein kinase II modulates mPer1 and mPer2 gene induction and influences phase shifts of the circadian clock. Curr Biol 2003; 13: 725-733.
29. Masumoto KH, Fujioka A, Nakahama K, Inouye ST, Shigeyoshi Y. Effect of phosphodiesterase type 4 on circadian clock gene Per1 transcription. Biochem Biophys Res Commun 2003; 306: 781-785.
30. Hirota T, Okano T, Kokame K, Shirotani-Ikejima H, Miyata T, Fukada Y. Glucose down-regulates Per1 and Per2 mRNA levels and induces circadian gene expression in cultured Rat-1 fibroblasts. J Biol Chem 2002; 277: 44 244-44 251.
31. Motzkus D, Albrecht U, Maronde E. The human PER1 gene is inducible by interleukin-6. J Mol Neurosci 2002; 18: 105-109.
32. Motzkus D, Maronde E, Grunenberg U, Lee CC, Forssmann W, Albrecht U. The human PER1 gene is transcriptionally regulated by multiple signaling pathways. FEBS Lett 2000; 486: 315-319.
33. Cermakian N, Monaco L, Pando MP, Dierich A, Sassone-Corsi P. Altered behavioral rhythms and clock gene expression in mice with a targeted mutation in the Period1 gene. EMBO J 2001; 20: 3967-3974.
34. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science 2003; 302: 255-259.
35. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002; 111: 41-50.